As Halo's first customer, Baxter has always been an early adopter in R&D partnering. Matt Muller (Applied Innovation at Baxter) shared takeaways from Baxter's kidney dialysis research engagements on Halo, including surprising new partners.
In January, Halo kicked off our program with Baxter (NYSE: BAX), a Fortune 500 medical device company with a focus on kidney disease, immune disorders and other chronic conditions. Baxter was seeking new technologies to purify tap water to make it...
Meet the 40 under 40 Chicago scientists dedicated to translating research into real-world applications.